Land: Nederland
Taal: Nederlands
Bron: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
DIENOGEST 2 mg/stuk ; ESTRADIOLVALERAAT 1 mg/stuk SAMENSTELLING overeenkomend met ; ESTRADIOL 0,76 mg/stuk
Laboratorios Leon Farma, S.A. C/La Vallina s/n, Pol. Ind. 24008 NAVATEJERA (SPANJE)
G03FA15
DIENOGEST 2 mg/stuk ; ESTRADIOLVALERAAT 1 mg/stuk SAMENSTELLING overeenkomend met ; ESTRADIOL 0,76 mg/stuk
Filmomhulde tablet
IJZEROXIDE ROOD (E 172) ; IJZEROXIDE ZWART (E 172) ; LACTOSE 1-WATER ; MACROGOL 3350 ; MAGNESIUMSTEARAAT (E 470b) ; MAÏSZETMEEL ; MAÏSZETMEEL, GEPREGELATINEERD ; POLYVINYLALCOHOL (E1203) ; POVIDON K 30 (E 1201) ; TALK (E 553 B) ; TITAANDIOXIDE (E 171),
Oraal gebruik
Dienogest And Estrogen
Hulpstoffen: IJZEROXIDE ROOD (E 172); IJZEROXIDE ZWART (E 172); LACTOSE 1-WATER; MACROGOL 3350; MAGNESIUMSTEARAAT (E 470b); MAÏSZETMEEL; MAÏSZETMEEL, GEPREGELATINEERD; POLYVINYLALCOHOL (E1203); POVIDON K 30 (E 1201); TALK (E 553 B); TITAANDIOXIDE (E 171);
2014-09-26
9 LF-DIE-EV-NL/H/2949/002/IB/021 PACKAGE LEAFLET: INFORMATION FOR THE USER Estradiol Valeraat 1 mg / Dienogest 2 mg Laboratorios Léon Farma, filmomhulde tabletten estradiol valerate and dienogest READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. WHAT IS IN THIS LEAFLET 1. What < Invented Name > is and what it is used for 2. What you need to know before you take < Invented Name > 3. How to take < Invented Name > 4. Possible side effects 5. How to store < Invented Name > 6. Contents of the pack and other information 1. WHATIS AND WHAT IT IS USED FOR < Invented Name > is a Hormone Replacement Therapy (HRT). It contains two types of female hormones, an oestrogen and a progestogen. Lees het volledige documentis used in postmenopausal women with at least 12 months since their last natural period. < Invented Name > is used for: RELIEF OF SYMPTOMS OCCURRING AFTER MENOPAUSE During the menopause, the amount of oestrogen produced by a woman’s body drops. This can cause symptoms such as hot face, neck and chest (“hot flushes”). alleviates these symptoms after menopause. You will only be prescribed if your symptoms seriously hinder your daily life. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MEDICAL HISTORY AND REGULAR CHECK-UPS The use of HRT carries risks which need to be considered when deciding whether to start taking it, or whether to carry on taking it. 10 LF-DIE-EV-NL/H/2949/002/IB/021 The experience in treating women with a premature menopause (due to ovarian failure or surgery) is limited. If
1 SPC-DIE-EV-NL/H/2949/002/I B/021 SUMMARY OF PRODUCT CHARACTERISTICS ESTRADIOL VALERAAT 1 MG / DIENOGEST 2 MG LABORATORIOS LÉON FARMA, FILMOMHULDE TABLETTEN ESTRADIOL VALERATE / DIENOGEST 1. NAME OF THE MEDICINAL PRODUCT Estradiol Valeraat 1 mg / Dienogest 2 mg Laboratorios Léon Farma, filmomhulde tabletten 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains: estradiol valerate 1.0 mg (equivalent to 0.764 mg estradiol) and dienogest 2.0 mg Excipients with know effect: each tablet contains 58.22 mg of lactose monohydrate. For full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet Tablets are light pink and rounded with a diameter of 6 mm approx. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC I NDICATIONS Hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women more than one year post menopause. Experience of treating women older than 65 years is limited. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY How to start1 mg/2 mg Women who do not take hormone replacement therapy (HRT) or women who change from another continuous combined HRT product may start treatment at any time. Women changing from a continuous sequential HRT regimen should begin the day following completion of the prior regimen. Women changing from a cyclic HRT regimen should begin the day after the treatment-free period. One tablet is taken daily. Each blister pack contains tablets for 28 days of treatment. Method of Aadministration For oral use. 2 SPC-DIE-EV-NL/H/2949/002/I B/021 The tablets are to be swallowed whole with some liquid. Treatment is continuous, which means that the next pack follows immediately without a break. The tablets should preferably be taken at the same time every day. In case a tablet is forgotten it should be taken as soon as possible. If more than 24 hours have elapsed no extra tablet needs to be taken. If several tablets are forgotten, bleeding may occur. For initiation and continuation of treatment of postmenopausal sym Lees het volledige document